| Amy Christine Lorash, MS | |
|
2747 Enterprise Ave Ste 5, Billings, MT 59102-7412 | |
| (406) 534-2087 | |
| Not Available |
| Full Name | Amy Christine Lorash |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2747 Enterprise Ave Ste 5, Billings, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881929024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1208 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Christine Lorash, MS Po Box 81703, Billings, MT 59108-1703 Ph: (406) 534-2087 | Amy Christine Lorash, MS 2747 Enterprise Ave Ste 5, Billings, MT 59102-7412 Ph: (406) 534-2087 |
News Archive
The air your teenage daughter breathes may be causing irregular menstrual cycles. Well documented negative health effects from air pollution exposure include infertility, metabolic syndrome and polycystic ovary syndrome.
Osteologix, Inc., a bio-pharmaceutical company announced today that the company will continue the clinical development for its osteoporosis drug, NB S101 (strontium malonate), in the United States and the rest of the world markets. Additionally, the company wants to recognize World Osteoporosis Day's significance and make more people aware of its research dedicated to improving the lives of people with osteoporosis.
Chinese HIV/AIDS advocate and retired physician Gao Yaojie on Thursday said she remains under house arrest despite abandoning plans to visit the U.S. to accept an award from the group Vital Voices Global Partnership, the New York Times reports
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
By identifying a protein that acts as a genetic modifier, scientists at Cold Spring Harbor Laboratory have solved the mystery of why some infants are born with a grave syndrome consisting of cleft palate and major deformities of the skin and limbs, while other infants bearing the same predisposing genetic mutation bear little or no sign of the illness, called EEC.
› Verified 7 days ago
Mrs. Brooke Leigh Oftedal, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1750 Morocco Dr, Billings, MT 59105 Phone: 406-671-1854 | |
Jessica Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1597 Avenue D Ste 4, Billings, MT 59102 Phone: 406-690-6996 | |
Kathryn Marie Satterfield, MCSDCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3940 Rimrock Rd, Billings, MT 59102 Phone: 406-655-5658 Fax: 406-655-5639 | |
Emily Berendts Anderson, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Latisha Lee Montgomery, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-7166 | |
Rock Creek Teletherapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1302 24th St W, Suite 132, Billings, MT 59102 Phone: 888-241-4332 Fax: 406-794-0454 | |
Kelly Marie Geary Ruggles, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 Broadwater Ave, Billings, MT 59101 Phone: 406-259-1680 Fax: 406-259-1777 |